www.excelsiorsolutions.com Open in urlscan Pro
209.240.94.12  Public Scan

Submitted URL: http://excelsiorsolutions.com/
Effective URL: http://www.excelsiorsolutions.com/
Submission: On March 07 via manual from US — Scanned from DE

Form analysis 2 forms found in the DOM

GET http://www.excelsiorsolutions.com/

<form aria-label="Search this website" role="search" method="get" class="searchform" action="http://www.excelsiorsolutions.com/">
  <input aria-label="Insert search query" type="search" id="ocean-search-form-1" class="field" autocomplete="off" placeholder="Search" name="s">
</form>

GET http://www.excelsiorsolutions.com/

<form aria-label="Search this website" method="get" action="http://www.excelsiorsolutions.com/" class="mobile-searchform">
  <input aria-label="Insert search query" value="" class="field" id="ocean-mobile-search-2" type="search" name="s" autocomplete="off" placeholder="Search">
  <button aria-label="Submit search" type="submit" class="searchform-submit">
    <i class=" icon-magnifier" aria-hidden="true" role="img"></i> </button>
</form>

Text Content

Skip to content
 * Home
 * Services
   * Audit Services
   * PBM Consulting
   * Specialty Drug Management
   * Medicare & Medicaid
 * Pharmacy Audit Services
 * About Us
 * Leadership
 * Insights & Publications
   * Case Studies
   * Newsletters
   * Industry News
 * Contact Us
 * Toggle website search


Menu Close
 * Home
 * Services
   * Audit Services
   * PBM Consulting
   * Specialty Drug Management
   * Medicare & Medicaid
 * Pharmacy Audit Services
 * About Us
 * Leadership
 * Insights & Publications
   * Case Studies
   * Newsletters
   * Industry News
 * Contact Us
 * Toggle website search




THE EXCELSIOR SOLUTIONS DIFFERENCE


PBM CONSULTING

Substantially reducing pharmacy benefit costs without sacrificing plan quality.




SPECIALTY DRUG MANAGEMENT

Managing one of the largest hidden costs of medical care.




MEDICARE & MEDICAID

Navigating a complex marketplace.






ABOUT US

Your cutting-edge expert with the resources to manage your pharmacy program
effectively, contain cost, and be accountable for the results. We are the next
generation; we are the solution.

Read More


INSIGHTS & PUBLICATIONS


NEWSLETTERS


Q1 2023 EXCELSIOR NEWSLETTER

Drug Trends to Watch, Actions to Consider by Robert Kordella, RPh, MBASenior
Vice President and Chief Clinical Officer DIABETES Rising prescription costs
related to the


Q3 2022 EXCELSIOR NEWSLETTER

Excelsior’s Opinion on So-Called “Vision Enhancement Products” by Robert
Kordella, RPh, MBA, Chief Clinical Officer Three products have come to market
recently that are being


Q2 2022 EXCELSIOR NEWSLETTER

Humira Savings on the Horizon? by Robert Kordella, RPh, MBA, Chief Clinical
Officer In 2021, Humira (adalimumab) amassed $21 billion in sales in the U.S.


CASE STUDIES


PHARMACY RENEGOTIATION THROUGH EXCELSIOR SOLUTIONS

Pharmacy renegotiation through Excelsior Solutions Annual Pharmacy Savings
of $6.3M (23%


USING DATA TO IDENTIFY FRAUDULENT CLAIMS

Using Data to Identify Fraudulent Claims Pharmacy Reimbursement of  $26,000
Challenge


OPIOID CASE STUDY

Opioid Case Study Annual Savings of  $192,000 Challenge Member filling pain


INDUSTRY NEWS


BIOSIMILARS: IS THE PROMISE OF SAVING BEING REALIZED BY HEALTH PLANS

With increasing specialty drug costs, pharmacy benefit managers,health plans and
industry experts often tout the use of biosimilarsas a strategy to lower cost.
In 2013,


HUMALOG LISPRO NEWS

As you may recall, back in March of this year, Eli Lilly announced that they
would begin to manufacture and sell an authorized generic version


GENERIC ADVAIR DISKUS APPROVED

The news that the FDA approved the first A-rated (meaning that pharmacists may
freely substitute it without physician approval) generic form of Advair Diskus
on


ICER UPDATE 10.04.22

 Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER
Update. ICER released a Final Evidence Report assessing the comparative clinical
effectiveness and value


ICER UPDATE 01.27.22

Hello everyone, and welcome to this edition of Excelsior Solutions’ ICER Update.
ICER has published its latest report on Unsupported Price Increases (UPI) of
prescription


ICER UPDATE 01.22.21

Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER
Update. Here is this week’s ICER recap: ICER has published its latest report on




SERVICES

 * PBM Consulting
 * Specialty Drug Management
 * Medicare & Medicaid


COMPANY

 * About Us
 * Leadership
 * Insights & Publications
 * Contact Us
 * Privacy Policy


EXCELSIOR SOLUTIONS

7650 Edinborough Way
Suite 100
Edina, MN 55435
(952) 657-5457


© Copyright 2019 Excelsior Solutions • Privacy Policy • All Rights Reserved